Ibogaine vs. Methadone
Comparing ibogaine therapy with methadone maintenance for opioid addiction treatment.
Ibogaine
- • Single treatment session
- • Resets dopamine reward system
- • No ongoing opioid dependency
- • Available in Mexico (legal, unregulated)
- • 5-14 day clinic program
- • Promotes neuroplasticity and neural repair
- • Requires comprehensive cardiac monitoring
- • Growing but limited clinical evidence
Methadone
- • Daily medication at licensed clinic
- • Full opioid agonist (stronger than Suboxone)
- • Maintains opioid dependency
- • Available in the US at methadone clinics
- • Requires daily or near-daily clinic visits
- • Decades of clinical evidence
- • Well-understood side effect profile
- • Difficult to taper off (long half-life)
The Bottom Line
Methadone has been the gold standard for severe opioid addiction treatment for decades and has helped millions stabilize their lives. However, it requires daily clinic visits, maintains opioid dependency, and can be very difficult to discontinue. Ibogaine offers a fundamentally different approach — a single treatment aimed at ending dependency rather than maintaining it. Important note: transitioning from methadone to ibogaine requires careful medical management due to methadone's long half-life and interaction risks.
The Ibogaine Briefing
Stay informed — get the latest ibogaine research, news, and stories delivered to your inbox.
We respect your privacy. Unsubscribe anytime.
Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Ibogaine treatment carries serious risks including cardiac complications. Always consult a qualified healthcare provider before pursuing any treatment.